Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Breast (Edinburgh, Scotland)|February 18, 2014
Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER dataO Brouckaert, A Laenen, A Smeets, et al.
European Journal of Cancer Care|March 11, 2015
Dealing with chemotherapy-related symptoms at home: a qualitative study in adult patients with cancerA Coolbrandt, B Dierckx de Casterlé, H Wildiers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequenceH Wildiers, B Ahmed, G Guetens, et al.
Breast (Edinburgh, Scotland)|April 10, 2013
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancersO Brouckaert, A Laenen, H Wildiers, et al.
ESMO Open|July 16, 2021
Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3L De Cock, J Heylen, A Wildiers, et al.
British Journal of Cancer|June 12, 2003
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11H Wildiers, G Guetens, G De Boeck, et al.
Journal of Clinical Pathology|June 30, 2009
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1S Pintens, P Neven, M Drijkoningen, et al.
Breast Cancer Research and Treatment|July 24, 2010
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancerH Wildiers, C Fontaine, P Vuylsteke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Breast Cancer Research and Treatment|May 9, 2019
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalB M Aarts, E G Klompenhouwer, R C Dresen, et al.
Pageof 9